https://www.selleckchem.com/products/ly333531.html
Findings were similar in treatment-naïve patients (mean ± SE hemoglobin concentration and platelet count, 12.8 ± 0.3 g/dL to 13.5 ± 0.2 g/dL and 168,821 ± 14,368/mm3 to 204,641 ± 16,071/mm3, respectively). Taliglucerase alfa was well-tolerated for up to 33 months and demonstrated a durable therapeutic effect. Quartz crystal microbalance studies have been carried out to monitor the fusion of lipid vesicles (pure 1,2-dimyristoyl-sn-glycero-3-phosphocholine, DMPC) and mixed vesicles (DMPC and 4-decylaniline). In order to increase the stab
Like
Comment
Share
